Nisa Investment Advisors LLC Sells 67,370 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Nisa Investment Advisors LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 74.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,561 shares of the pharmacy operator’s stock after selling 67,370 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $202,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in WBA. New Covenant Trust Company N.A. purchased a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at about $35,000. Iron Horse Wealth Management LLC raised its stake in Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares in the last quarter. Blue Trust Inc. lifted its position in Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares during the last quarter. Continuum Advisory LLC grew its stake in Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth $34,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

WBA has been the subject of several research reports. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Bank of America cut their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. UBS Group raised their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. JPMorgan Chase & Co. reduced their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, Barclays boosted their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.23 on Thursday. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The firm has a market cap of $7.98 billion, a P/E ratio of -0.92, a P/E/G ratio of 1.22 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05. The firm has a 50-day moving average of $9.18 and a 200-day moving average of $12.30.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period last year, the company earned $0.67 EPS. Sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 10.83%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.